Related Experiment Video

Updated: May 19, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Genetic prediction of radiation-induced morbidity in prostate cancer patients

Tanja Langsenlehner, Eva-Maria Thurner, Sabine Krenn-Pilko

    Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
    |August 22, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    Related Experiment Videos

    Last Updated: May 19, 2026

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
    13:19

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

    Published on: November 2, 2013

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    Related Concept Videos

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
    Cancer Prevention02:59

    Cancer Prevention

    Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
    Some...

    Articles linked to this work by shared authors, journal, and citation graph.

    Ultrahypofractionated linac-based radiotherapy of primary prostate cancer - early results of an Austrian nationwide registry study.

    Clinical and translational radiation oncology·2026

    Mitochondrial DNA copy number in leukocytes predicts long-term survival in prostate cancer.

    Clinical chemistry and laboratory medicine·2026

    A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrence.

    NPJ breast cancer·2026

    Leukocyte telomere attrition following radiotherapy in prostate cancer: a prospective study.

    Scientific reports·2026

    Evaluation of urinary cfDNA workflows for the molecular profiling of malignant disease.

    iScience·2025

    Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE.

    International journal of cancer·2025

    Repeated metastasis-directed radiotherapy in patients with oligorecurrent prostate cancer: outcomes and risk stratification from a large multinational PSMA PET-guided cohort.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    Selective lipid Metabolic remodelling in radiosensitive normal tissues after FLASH radiotherapy.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    Multi-center comparison of relative stopping power estimation of an ex vivo phantom using clinical X-ray CT scanners and a proton CT prototype.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    Deep learning-based spot weight generation for online adaptive IMPT: implementation and technical feasibility on a clinical delivery system.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    Initial complete local therapy without systemic therapy versus systemic-therapy-based management in selected patients with oligometastatic renal cell carcinoma: a matched comparative study.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    Uncertainty quantification for detecting out-of-distribution cases in deep learning segmentation of head and neck organs of interest.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us